- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04559373
Virtual Reality and Field Training to Enhance Community Walking After Stroke
A Virtual Reality and Field Training Toolkit to Enhance Community Ambulation and Participation in Stroke Survivors
While stroke survivors discharged from rehabilitation present with some recovery in mobility, their ability to ambulate in the community remains limited. The investigators propose to test a novel, low-cost, intensive and individually tailored intervention that combines virtual reality (VR) and field training to enhance community ambulation and participation in stroke survivors discharged from rehabilitation.
The aims are to: (1) Assess feasibility, acceptability, safety and adherence of the intervention in stroke survivors; and (2) Examine the extent to which post-intervention changes in functional walking and participation to community walking vary according to walking, cognitive and visual-perceptual abilities.
The investigators will use a virtual environment prototype simulating a shopping mall and surrounding streets, in which participants will interact using VR goggles and game controllers. Scenarios of increasing levels of complexity will be introduced. This intervention study involves a single group, multiple pre- multiple post- study design where chronic stroke participants will engage in a 4-week training program. The program will include VR training sessions performed in the clinical setting (3/week) and practice of community ambulation skills while supervised by family/caregivers (2/week). Participants will be assessed on measures of functional walking, balance & mobility and participation to community walking. Adherence, safety and acceptability will be documented. This study will generate foundation knowledge on the response to the intervention based on individual capacities.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Ambulating in community environments requires the skills to cope with multiple, simultaneous dimensions such as walking speed and distance, etc. Such skills remain compromised in the majority of stroke survivors due to insufficient or lack of targeted practice. The investigators propose to test a new, individually-tailored intervention, developed by the research team, grounded in best evidence in community ambulation, principles of motor learning and participatory action research. This unique intervention will combine virtual reality (VR) and field training practice to optimize learning that can be generalized to daily walking activities.
Participants will engage in the 4-week, individually-tailored intervention that comprises of supervised VR training sessions (3 times/week) performed in the clinical setting. VR sessions will be completed by field training assignments. Subjects will be assessed twice prior to the intervention, immediately after the intervention and at follow up.
Generalized estimating equations will be used to compare changes in main and secondary outcomes across time points, with each personal factor of interest (e.g. walking capacity, visual-perceptual function, and cognitive function) analyzed individually while adjusting for age. Outcomes on adherence, safety and acceptability will be analyzed with descriptive statistics.
Required sample size was estimated based on Green's rule (effect size=0.5, power=80%, α=0.05) with a variance inflation factor assuming moderate within-subject correlations for 3 post-baseline measurement time points. This yields a sample size of 30. Assuming a worst-case scenario of 30% attrition rate, a total of 40 stroke subjects (20/site) will be recruited.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anouk Lamontagne, PhD
- Phone Number: 514-938-4397
- Email: anouk.lamontagne@mcgill.ca
Study Contact Backup
- Name: Andréanne Blanchette, PhD
- Phone Number: 403579 418-656-2131
- Email: andreanne.blanchette@fmed.ulaval.ca
Study Locations
-
-
-
Québec, Canada, G1W 1P7
- Not yet recruiting
- Institut de réadaptation en déficience physique de Québec
-
Contact:
- Andréanne Blanchette, PhD
- Phone Number: 403579 418-656-2131
- Email: andreanne.blanchette@fmed.ulaval.ca
-
-
Quebec
-
Laval, Quebec, Canada, H7V1R2
- Recruiting
- Jewish Rehabilitation Hospital
-
Contact:
- Anouk Lamontagne, PhD
- Phone Number: 84168 450-688-9550
- Email: anouk.lamontagne@mcgill.ca
-
Contact:
- Vira Rose
- Phone Number: 84300 450-688-9550
- Email: vrose_hjr@ssss.gouv.qc.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
People with chronic stroke and persistent deficits in walking / visual-perceptual / cognitive capacities. They can be male or female, aged from 40 to 74 years, with normal/corrected visual and auditory acuity, and present with:
- First-ever supratentorial unilateral stroke 9-24 months ago (such chronicity will ensure steady-state mobility without long-term disuse-related changes
- Mild-to-moderate hemiparesis (Chedoke McMaster Stoke Assessment stages 4/7-6/7 on postural control, leg & foot)
- Ability to walk independently with/without walking aids for at least 1 min at 0.4-0.9 m/s (such a speed range indicates mobility not sufficient for functional community ambulation: shopping ~1.1m/s, street crossing ~1.2 m/s)
- Intact or mildly affected cognitive function (Montreal Cognitive Assessment scores ≥ 22/30)
- Intact to moderately affected visual-perceptual function (positive scores on a maximum of 3/6 tasks on the Behavioural Inattention Test)
Exclusion Criteria:
- Subjects with comorbidities interfering with walking
- Subjects with comorbidities interfering with visual perception
- Subjects without medical clearance for exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual Reality and Field Practice Training (VRFT)
Participants will engage in a 4-week VRFT intervention that comprises of 1-hour training sessions, 3 times/week.
|
The VRFT intervention involves the intensive practice of community ambulation skills.
Some of the training sessions will be performed in a virtual environment, while others will consist of field training exercises in the community.
During the intervention, stroke participants will be invited to practice different dimensions of community ambulation, such as postural transitions, avoiding other pedestrians, dual-task walking, etc.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-intervention change in the Six Minute Walk Test (6MWT)
Time Frame: Pre-intervention (Week4) and post-intervention (Week8)
|
The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface.
The goal is for the individual to walk as far as possible in six minutes.
The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.
|
Pre-intervention (Week4) and post-intervention (Week8)
|
Change in the Six Minute Walk Test (6MWT) at Follow-up
Time Frame: Post-intervention (Week8) and Follow-up (Week12)
|
The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface.
The goal is for the individual to walk as far as possible in six minutes.
The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.
|
Post-intervention (Week8) and Follow-up (Week12)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dynamic Gait Index
Time Frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Developed to assess the likelihood of falling in older adults
|
Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
5m Walk Test
Time Frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Assesses walking speed in meters per seconds over a short duration
|
Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Activities-Specific Balance Confidence Scale
Time Frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
16-item self-reported measure of balance confidence performing various activities without losing balance or experiencing a sense of unsteadiness.
Items are rated on a 0%-100% response scale, with a score of 0 representing no confidence and a score of 100 representing complete confidence.
|
Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Trip Activity Log
Time Frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Questionnaire to record the number of trips and walking-related activities in the community (e.g.
outside home) 3 days preceding its administration
|
Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Environmental Analysis of Mobility Questionnaire
Time Frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Self-reported tool to assess mobility problems due to the environment
|
Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Assessment of Life Habits (Life-H: mobility and community life domains)
Time Frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Assesses mobility and community life habits based on the levels of accomplishment and assistance required as well as satisfaction
|
Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to intervention
Time Frame: 3x/week over the 4-week intervention for the virtual reality component; 2x/week over the 4-week intervention for the field training component
|
Training logbook filled by researchers/clinicians (virtual reality) and subjects (field training) component)
|
3x/week over the 4-week intervention for the virtual reality component; 2x/week over the 4-week intervention for the field training component
|
Safety of the intervention
Time Frame: 3x/week over the 4-week intervention of the virtual reality component
|
Assesses by systematically collecting any occurrence of adverse/unwanted events (falls, injuries, fatigue, etc).
|
3x/week over the 4-week intervention of the virtual reality component
|
Acceptability of the intervention
Time Frame: Post-intervention (Week8)
|
Assesses using the Technology Acceptance Model based Questionnaire (Tam-Q) based on the technology acceptance model, in which subjects will rate their perception on each dimension using a visual analog scale ranging from 0-56, with higher score representing higher acceptance to the intervention.
|
Post-intervention (Week8)
|
Cadence
Time Frame: Pre-intervention (Week4) and post-intervention (Week8)
|
Cadence is the rate at which a person walks (steps per minute) and will be measured with the GaitRite system.
|
Pre-intervention (Week4) and post-intervention (Week8)
|
Step length
Time Frame: Pre-intervention (Week4) and post-intervention (Week8)
|
Step length is the distance (in meters) from a point of contact with the ground of one foot to the following occurrence of the same point of contact with the other foot and will be measured with the GaitRite system.
|
Pre-intervention (Week4) and post-intervention (Week8)
|
Step duration
Time Frame: Pre-intervention (Week4) and post-intervention (Week8)
|
Step duration is the period of time (in seconds) taken for one step is measured from an event of one foot to the following occurrence of the same event with the other foot and will be measured with the GaitRite system.
|
Pre-intervention (Week4) and post-intervention (Week8)
|
Stance phase
Time Frame: Pre-intervention (Week4) and post-intervention (Week8)
|
Stance phase is the period of time when the foot is in contact with the ground (%) and will be measured with the GaitRite system.
|
Pre-intervention (Week4) and post-intervention (Week8)
|
Swing phase
Time Frame: Pre-intervention (Week4) and post-intervention (Week8)
|
Swing phase is the period of time when the foot is not in contact with the ground (%) and will be measured with the GaitRite system.
|
Pre-intervention (Week4) and post-intervention (Week8)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Anouk Lamontagne, PhD, McGill University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PJT-148917
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Virtual Reality and Field Training (VRFT)
-
University of MiamiCompletedVisual Field Defect, Peripheral | Visual Field Defect, Nasal Step | Visual Field Defect, Paracentral Scotoma of Both EyesUnited States
-
Imam Abdulrahman Bin Faisal UniversityKing AbdulAziz City for Science and TechnologyCompletedMultiple SclerosisSaudi Arabia
-
University of California, Los AngelesSuspendedDepression | Mood Disorders | Anhedonia | Stress | Anxiety | Virtual RealityUnited States
-
Riphah International UniversityCompleted
-
University of MiamiEnrolling by invitationGlaucomaUnited States
-
Luzerner KantonsspitalRecruitingParkinson DiseaseSwitzerland
-
IRCCS Eugenio MedeaUniversidad de Burgos; Asociatia Bucuresti Pentru Copii Dislexici; Augumented...Completed
-
Universidade do Oeste PaulistaUnknownCardiovascular Diseases | Body CompositionBrazil
-
Indiana UniversityCompletedAdolescent | Child | Attention Deficit and Disruptive Behavior Disorders | Conduct Disorder | Magnetic Resonance Imaging | Virtual Reality | Child Behavior Disorders | Social PerceptionUnited States
-
TOPMEDConseil de recherches en sciences naturelles et en génie du Canada; SEC Fonds...Recruiting